Yoga shows remarkable benefit for vasovagal syncope patients, JACC study. dr. Abhimanyu Uppal6 Dec 2021 10:39 AM ISTTreatment of vasovagal syncope (VVS) patients has hitherto proven to be difficult, with various treatment modalities showing a modest benefit if any....
ApoB/ApoA-1 ratio- New way of identifying early risk of cardiovascular disease Dr. Kamal Kant Kohli6 Dec 2021 10:30 AM ISTThe risk of developing cardiovascular disease is strongly associated with the "bad" LDL cholesterol. A large study by scientists at Karolinska...
Rivaroxaban and aspirin combo improves CV outcomes in stable ASCVD: COMPASS Trial MD Editorial Team4 Dec 2021 1:50 PM ISTCardiovascular diseases are the leading cause of death globally. Though new medications and the use of effective secondary prevention strategies, 5%...
 Prehospital High-Sensitivity Cardiac Troponin Test can rule out MI MD Bureau4 Dec 2021 10:21 AM ISTThe last decade has seen an increased focus on diagnostic assessment with troponins outside of hospitals. Point-of-care (POC) troponin assays, used in...
Beta blocker withdrawal in HFpEF increases functional and exercise capacity: study Dr. Shravani Dali4 Dec 2021 10:00 AM ISTShort-term β-blocker withdrawal is tied with the improvement of clinical outcomes and exercise capacity in HFpEF patients, according to a recent...
Early Dialysis initiation in CKD may reduce CV events and mortality: BMJ Dr. Shravani Dali4 Dec 2021 9:45 AM ISTDialysis should be started four years earlier to reduce mortality and CVD in advanced CKD, according to a recent study published in the BMJ. A...
Sacubitril-valsartan not tied to lower death risk versus ramipril in acute myocardial infarction: Study Medha Baranwal4 Dec 2021 9:00 AM ISTUSA: A recent study suggests that in patients with acute myocardial infarction, sacubitril-valsartan did not significantly lower death risk from...
Oral PCSK9 inhibitor may significantly reduce LDL C levels: DALLAS, The First Human Trial Dr. Prem Aggarwal3 Dec 2021 2:07 PM ISTLow-density lipoprotein (LDL) cholesterol, popularly known as bad cholesterol is major cause of heart disease. LDL C causes build-up of fatty deposits...
Hyperglycemia tied to stent restenosis in STEMI patients undergoing PCI: Study Medha Baranwal3 Dec 2021 10:00 AM ISTNew York, NY: A recent study in the journal Diabetes Care indicates that hyperglycemia (HG) is associated with adverse outcomes in STEMI patients...
Obicetrapib given with high-intensity statins reduces LDL-C by 50 percent: Study Medha Baranwal3 Dec 2021 9:15 AM ISTUSA: Obicetrapib at doses of 5 and 10 mg largely reduced LDL-C in patients treated with high-intensity statins, according to results from the Rose...
Sacubitril/valsartan decreases plasma NT-proBNP in HF patients with preserved ejection fraction: JAMA Medha Baranwal3 Dec 2021 9:00 AM ISTGermany: Sacubitril/valsartan significantly decreased plasma NT-proBNP levels at 12 weeks compared with standard medical therapies in patients with...
Central catheters safer than PICCs for short-term venous access: JAMA Medha Baranwal3 Dec 2021 9:00 AM ISTUSA: Midline catheters versus peripherally inserted central catheters (PICCs) for short-term indications are associated with a lower risk of occlusion...
